Product

CVL-865

Aliases

PF-06372865

2 clinical trials

1 indication

Indication

Clinical trial

A 57-Week, Multicenter, Active-treatment, Open-label Extension Trial of CVL-865 as Adjunctive Therapy in Adults With Drug-Resistant Focal Onset Seizures

Status: , Estimated PCD: 2025-06-01

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter Trial of CVL-865 as Adjunctive Therapy in Adults With Drug-Resistant Focal Onset Seizures (REALIZE Trial)

Status: Recruiting, Estimated PCD: 2024-05-01